vectura

See: fare
Mentioned in ?
References in periodicals archive ?
Pangratz was previously working with Vectura Group as senior vice president of business development.
Propeller has partnered with several companies including Vectura Group to develop an add-on sensor for Vecturas lever-operated multi-dose inhaler.
Prior to that, he has held positions in technology-orientated companies including four successful years as Marketing and Sales director at Vectura AB.
See Hamer & Miller, supra note 128, at 45-46 (discussing cases such as Vectura and Matsushita Electric Industrial Co.
The UK Competition and Markets Authority has determined that a relevant merger situation, under the provisions of the Enterprise Act 2002, has not been created in the acquisition of UK-based pharmaceutical company Skyepharma plc (LSE: SKP) by UK-based pharmaceutical company Vectura Group plc (LSE: VEC), the CMA said.
9p Elsewhere in the FTSE 250 Index, pharmaceutical company Vectura rose 5.
USPRwire, Fri Sep 11 2015] Global Markets Direct's, 'Vectura Group plc - Product Pipeline Review - 2015', provides an overview of the Vectura Group plc's pharmaceutical research and development focus.
Company of Spirits AS, Edrington Norway AS, Robert Prizelius AS, Altia Plc (Interbev AS), Vectura AS, Bacardi Limited, Wiig Spirits AS, Others
COMPANIES REPORTING TODAY: Full-year results from Burberry, Cable & Wireless Communications, FirstGroup, Great Portland Estates, SSE, Stobart, Telecom Plus, Vectura and UK Mail TOMORROW: Full-year results from Dairy Crest, Electrocomponents, Halfords, Hogg Robinson Group, Investec, Mothercare, QinetiQ Group, Royal Mail, SABMILLER, United Utilities, Vtech Holdings, Young & CO's Brewery COMPANY FOCUS: NATIONAL GRID THE energy network operator reported its full-year results on ursday, which were broadly in line with company expectations.
Companies Mentioned in this Report: Ablynx, Vectura Group plc, Pharmaxis Ltd.
SeeNews) - Sep 30, 2013 -A Belgian biopharmaceuticals firm UCB SA (EBR:UCB) and UK sector playerA Vectura (LON:VEC) said today they would collaborate to developA an innovative biologic immunomodulatory product in the area of severe inflammatory respiratory disease.
based Vectura Group Plc, was likely driven by the lack of a route to get a substitutable product approved in the U.